Pharm

Hourly Subcutaneous Insulin

search

Hourly Subcutaneous Insulin, Hourly Subcutaneous Insulin Aspart, Hourly Subcutaneous Insulin Lispro

  • Protocol
  • Adults
  1. See Diabetic Ketoacidosis Management in Adults
  2. General
    1. Use subcutaneous Rapid-Acting Insulin (Lispro, Aspart)
    2. Coadminister fluids as per Diabetic Ketoacidosis
    3. Discontinue hourly dosing when Glucose 150-200
    4. Monitor serum electolytes, Serum Ketones, and Venous Blood Gas every 4 hours
  3. Hourly SQ Insulin Protocol
    1. Initial SQ bolus dose: 0.3 units/kg (other protocols start with 0.1 unit/kg)
    2. Next: 0.1 units/kg/hour SQ until Hyperglycemia corrects (Blood Glucose <250 mg/dl)
    3. Next: 0.05 units/kg/hour SQ until DKA resolves
  4. Every 2 hour SQ Insulin Protocol
    1. Initial SQ bolus dose: 0.3 units/kg
    2. Next: 0.2 units/kg every 2 hours SQ until Hyperglycemia corrects (Blood Glucose <250 mg/dl)
    3. Next: 0.1 units/kg every 2 hours SQ until DKA resolves
  • Protocol
  • Children
  1. See Diabetic Ketoacidosis Management in Children
  2. Precautions
    1. SQ Insulin for DKA Management is less established in children
  3. General
    1. Use subcutaneous Rapid-Acting Insulin (Lispro, Aspart)
    2. Coadminister fluids as per Diabetic Ketoacidosis
    3. Monitor serum electolytes, Serum Ketones, and Venous Blood Gas every 4 hours
  4. Every 2 hour SQ Insulin Protocol
    1. Give 0.1 to 0.15 units/kg every 1-2 hours
    2. Decrease dosing as Hyperglycemia corrects (Blood Glucose <250 mg/dl)
  • Precautions
  1. Correct Hypokalemia prior to Insulin Dosing
  2. Fluid administration is central to DKA treatment
  • Monitoring
  1. Blood Glucose every 30 minutes to 1 hour
  • Advantage over Insulin Infusion
  1. May be monitored on regular medical ward (non-ICU)
  2. Reduced cost by 39% compared with infusion
  • Safety and efficacy
  1. As effective and safe as Insulin Infusion